Literature DB >> 21603279

Serum resistin level in obese male children.

Anis Amirhakimi1, Hamdollah Karamifar, Hosein Moravej, Gholamhosein Amirhakimi.   

Abstract

Objectives. Resistin is a member of cysteine-rich molecules. Several studies have been carried out to determine the biological effect of resistin, nevertheless a significant number are animal studies. All the studies performed regarding the relationship between serum resistin and obesity were merely accomplished in women. To the best of our knowledge, there is no survey on the correlation of the serum resistin level and obesity in male children. The aim of the present study is to assess serum concentration of resistin in obese male children. Methods. Between June 2009 and January 2010, we enrolled 42 randomly selected obese male students (body mass index (BMI) >95th percentile, age 15.7 ± 1.5). Thirty-eight healthy age-matched male students with normal BMI (<85th percentile) were selected as a control group for the purpose of comparison of the serum resistin levels. Results. Serum resistin levels were measured in obese and control group. No significant difference was found between resistin levels of the 2 groups (obese: 9.21 ± 5.6 ng/mL versus normal: 9.83 ± 4.3 ng/mL; P = .582). There was no significant correlation between serum resistin level and BMI. Assessing the resistin level in male subjects was the distinct feature of our study. The outstanding finding of this research is that there is no correlation between serum resistin level and obesity. Conclusion. We have demonstrated that there is no correlation between obesity in male children and resistin level. Consequently, metabolic abnormalities of insulin resistance seen in obese male patients are not related to resistin.

Entities:  

Year:  2011        PMID: 21603279      PMCID: PMC3092673          DOI: 10.1155/2011/953410

Source DB:  PubMed          Journal:  J Obes        ISSN: 2090-0708


1. Introduction

Adipose tissue, involved in control of metabolism, is an active endocrine organ that secrets a number of hormones and cytokines termed adipocytokines [1-3]. These include leptin, interleukin-6, tumor necrosis factor-α, adiponectin, and resistin [2-10]. Adipocytokines have different effects and act through autocrine, paracrine, and endocrine pathways [11-14]. Having been recently identified as a novel adipocytokines, resistin is a members of cysteine-rich molecules [1]. Several studies have been carried out to determine the biological effect of resistin; nevertheless, a significant number of them have been animal studies. Recently, animal studies have shown that the serum resistin level remarkably rises in obese mice and that it may be a harbinger for insulin resistance and diabetes. Despite the fact that widespread research has been conducted to figure out the relationship between serum resistin and obesity, this issue still remains debated. One recent study evaluated serum resistin level in polycystic ovary syndrome, a metabolic disease linked with insulin resistance and obesity in women [15]. To the best of our knowledge, there are very limited surveys on the correlation of serum resistin level and obesity in children. The aim of the present study was to assess serum concentration of resistin in obese male children.

2. Materials and Methods

2.1. Study Population

Between June 2009 and January 2010, we enrolled 42 randomly selected obese male students (body mass index (BMI) >95th percentile, age 15.7 ± 1.5). Thirty-eight healthy age-matched male students with normal BMI (<85th percentile) were selected as a control group for the purpose of comparison of the serum resistin levels. Clinical history with thorough physical examination was performed in all subjects. Written informed consent was obtained from all students' parents before participation in the study. Subjects with the following characteristics were excluded from the study: (1) any pathological or suspicious clinical abnormality in history or physical examination (other than simple obesity), (2) short stature (height for age <10th percentile), (3) acute illness, and (4) abnormal laboratory data. The study protocol was approved by the local ethics committee.

2.2. Measurement of Serum Resistin

Blood samples were obtained and stored at −70°C until analysis. Serum resistin concentration was measured using a Human Resistin ELISA kit (EIA-4572, DRG instruments GmbH, Germany) in the Endocrinology and Metabolism Research Laboratory.

2.3. Statistical Analysis

All values are presented as mean ± SD. Comparisons between groups were made using Student's t-test. For all analyses, P-value <.05 was considered as statistically significant.

3. Results

3.1. Subjects Characteristics

Forty-two obese male students were randomly selected (age: 15.7 ± 1.5 yrs; BMI: 30.1 ± 4.3 kg/m2). Thirty-eight healthy age-matched male students with normal BMI (BMI: 18.7 ± 2.5 kg/m2) were selected as a control group. There was a statistically significant difference between BMI of obese subjects and normal students as expected (P = .001).

3.2. Serum Resistin Measurements

Serum resistin levels were measured in obese and control groups. No statistically significant difference was found between resistin levels of the 2 groups (obese: 9.21 ± 5.6 ng/mL versus control group: 9.83 ± 4.3 ng/mL; P = .582). There was no significant correlation between serum resistin level and BMI.

4. Discussion

Secreted by adipocytes, adipocytokines are proteins that play an important role in the regulation of energy [1, 5, 9]. Adipocytokines include leptin, adiponectin, and resistin [2-10]. Leptin is a hormone that reduces the appetite and enhances metabolism [16-18]. It appears that obese people produce more leptin because of increase in the number of fat cells [16-18]. Obesity is associated with insulin resistance, and leptin level is significantly correlated with insulin resistance [16, 17]. Adiponectin, a novel peptide present specifically in adipose tissue, has been appreciated to have inverse correlation with insulin resistance [19]. Resistin was originally recognized as a factor correlating obesity and diabetes by impairing insulin sensitivity in mice [1]. Preliminary animal studies put forward that obesity is associated with increased circulatory resistin concentrations [1]. Later studies, nonetheless, have determined opposite results, describing that resistin production goes down in obese rodents and is suppressed by free fatty acids. All the studies performed regarding the relationship between serum resistin and obesity were merely accomplished in women. Assessing the resistin level in male subjects was the distinct feature of the present study. The outstanding finding of this research is that no correlation between serum resistin level and obesity was found. Studies of resistin showed that resistin gene expression in 3T3-L1 adipocytes was inhibited by insulin and TNF-α which are increased in obesity [20]. Studies of resistin mRNA and protein expression in adipose tissue of humans have provided additional support that resistin may not play a role in obesity in humans. One report found that isolated human adipocytes have very low resistin mRNA levels [21].

5. Conclusion

In conclusion, it is demonstrated that there is no correlation between obesity in male children and resistin level. Consequently, metabolic abnormalities of insulin resistance seen in male obese patients are not related to resistin.
  21 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Resistin, central obesity, and type 2 diabetes.

Authors:  C L McTernan; P G McTernan; A L Harte; P L Levick; A H Barnett; S Kumar
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

4.  Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells.

Authors:  Nobuhiro Shojima; Hideyuki Sakoda; Takehide Ogihara; Midori Fujishiro; Hideki Katagiri; Motonobu Anai; Yukiko Onishi; Hiraku Ono; Kouichi Inukai; Miho Abe; Yasushi Fukushima; Masatoshi Kikuchi; Yoshitomo Oka; Tomoichiro Asano
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

5.  Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

Authors:  Krzysztof C Lewandowski; Konrad Szosland; Chris O'Callaghan; Bee K Tan; Harpal S Randeva; Andrzej Lewinski
Journal:  Mol Genet Metab       Date:  2005-02-12       Impact factor: 4.797

6.  Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Authors:  D B Savage; C P Sewter; E S Klenk; D G Segal; A Vidal-Puig; R V Considine; S O'Rahilly
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

Review 7.  Role of resistin in obesity, insulin resistance and Type II diabetes.

Authors:  Christine M Kusminski; Philip G McTernan; Sudhesh Kumar
Journal:  Clin Sci (Lond)       Date:  2005-09       Impact factor: 6.124

Review 8.  Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?

Authors:  Olavi Ukkola
Journal:  Eur J Endocrinol       Date:  2002-11       Impact factor: 6.664

9.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

Authors:  Joan Vendrell; Montserrat Broch; Nuria Vilarrasa; Ana Molina; Jose Manuel Gómez; Cristina Gutiérrez; Immaculada Simón; Joan Soler; Cristóbal Richart
Journal:  Obes Res       Date:  2004-06

10.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.

Authors:  Philip A Kern; Gina B Di Gregorio; Tong Lu; Negah Rassouli; Gouri Ranganathan
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

View more
  2 in total

1.  Concentrations of leptin, adiponectin, and resistin in the serum of obese cats during weight loss.

Authors:  Satoshi Takashima; Naohito Nishii; Yui Kobatake; Masaharu Kiyosue; Seiji Kimura; Hitoshi Kitagawa
Journal:  J Vet Med Sci       Date:  2019-08-01       Impact factor: 1.267

2.  Measurement of Plasma Resistin Concentrations in Horses with Metabolic and Inflammatory Disorders.

Authors:  Beatriz Fuentes-Romero; Alberto Muñoz-Prieto; José J Cerón; María Martín-Cuervo; Manuel Iglesias-García; Escolástico Aguilera-Tejero; Elisa Díez-Castro
Journal:  Animals (Basel)       Date:  2021-12-30       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.